Intended for healthcare professionals


Judge dismisses test case on third generation pill

BMJ 2002; 325 doi: (Published 03 August 2002) Cite this as: BMJ 2002;325:237
  1. Clare Dyer, legal correspondent
  1. BMJ

    Third generation contraceptive pills, whose sales plummeted after the 1995 “pill scare,” carry no higher risks of venous thromboembolism than second generation pills, a high court judge ruled this week.

    Mr Justice Mackay made his ruling in a group action by 99 women against three manufacturers of third generation oral contraceptives—Schering Health Care, Organon Laboratories, and John Wyeth and Brother. The women, who had strokes, pulmonary embolisms, and deep vein thromboses, argued that the newer pills were defective products as defined by the Consumer Protection Act.

    The judge described the 42 days of expert evidence …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription